Fri, Jul 25, 2014, 6:01 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

  • stockkarr stockkarr Dec 2, 2009 3:03 PM Flag

    R&D Day News/updates?

    Anyone? See that it is today, but haven't looked at any materials or anything. If anyone has any thoughts/comments - they are always appreciated by many, I know.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I sort of halfway listened to it while I was doing other stuff.

      Interesting that Dr. Scangos at lest tacitly acknowledged that a takeover was possible at any time.

      The 125 mg XL184 data set looks good, but numgers are too small to draw any definitive conclusions.

      • 1 Reply to erniewerner
      • Interesting - thank you both for sharing your thoughts.

        I wouldn't be surprised if they've received an initial offer from BMY - if you look on the negotiation history of MEDX, the first foray was probably a lowball offer. The wrinkle here is that the overall market situation was reversed.

        This is all guess work - but if there is no new partnership by EOY, strategic direction might be focused on a negotiated takeover. Either way - compelling reasons to accumulate.

    • I only caught the tail end of the call but scanned through the slides. There was some encouraging data on XL184 as we have recently seen plus a description of some their efforts/trials with XL184 now enrolling to explore other potential indications. There was also a significant amount of time dedicated to XL147 and XL765 combination trials.

      Additionally there was mention of some of their pre-clinical compounds that should garner (or already have) partnership interest IMO. I expect the practice of partnering these early with 0 or close to 0% development cost share in exchange for development milestones to continue for the next few years until they have real revenue to subsidize their R&D.

 
EXEL
4.19-0.02(-0.48%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.